Needham Investment Management LLC Voyager Therapeutics, Inc. Transaction History

Needham Investment Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$4.61 - $9.04 $654,269 - $1.28 Million	-141,924 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$7.15 - $12.28 $164,993 - $283,373	-23,076 Reduced 13.99%	141,924 $1.02 Million
Q3 2020 Nov 16, 2020	BUY	$10.01 - $13.75 $750,750 - $1.03 Million	75,000 Added 83.33%	165,000 $1.76 Million
Q1 2020 May 15, 2020	BUY	$6.8 - $14.66 $476,000 - $1.03 Million	70,000 Added 350.0%	90,000 $824,000
Q4 2019 Feb 14, 2020	BUY	$12.82 - $16.85 $256,400 - $337,000	20,000 New	20,000 $279,000

130

34.7M

39.7K

34.6K

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $216M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

Get notified when there are updates to the investment portfolio of Needham Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Needham Investment Management LLC with notifications on news.